相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4
Miriam E. Jaax et al.
BLOOD (2013)
Dynamic antibody-binding properties in the pathogenesis of HIT
Bruce S. Sachais et al.
BLOOD (2012)
Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay
D. Leroux et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)
Manali V. Joglekar et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Platelet factor 4 binds to bacteria-inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia
Krystin Krauel et al.
BLOOD (2011)
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice
Miranda M. C. van Beers et al.
PHARMACEUTICAL RESEARCH (2010)
Heparin-induced thrombocytopenia - therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes
K. Krauel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies
Andreas Greinacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia
D Juhl et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
TE Warkentin et al.
BLOOD (2005)
Immune response to immunotherapy:: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis
B Hemmer et al.
LANCET NEUROLOGY (2005)
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
L Rauova et al.
BLOOD (2005)
Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin
P Eichler et al.
BLOOD (2004)
Heparin-induced thrombocytopenia: Recognition, treatment, and prevention
TE Warkentin et al.
CHEST (2004)
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia
A Greinacher et al.
CIRCULATION (2003)
Circular dichroism spectra of short, fixed-nucleus alanine helices
DH Chin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
MA Rosenthal et al.
ANNALS OF ONCOLOGY (2002)
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody
ZQ Li et al.
BLOOD (2002)
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
N Casadevall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
